Come up with a name for your new list and we'll add to it:
TheraJect raised a round of funding on August 02, 2012. Investors include
National Science Foundation.
TheraJect is a preclinical stage biopharmaceutical company committed to the drug delivery including vaccines via a needle-free transdermal technology. TheraJect is focused on enhancing the efficacy of…